Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
Multiplex Assay Kit for Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) ,etc. by FLIA (Flow Luminescence Immunoassay)
NSP2; SH2D3B; Novel SH2-containing protein 2; SH2 domain-containing protein 3B
(Note: Up to 8-plex in one testing reaction)
- Product No.LMG768Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample TypeSerum, plasma, tissue homogenates and other biological fluids.
- Test MethodDouble-antibody Sandwich
- Assay Length3.5h
- Detection Range4.88-5000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 1.627 pg/mL.
- DownloadInstruction Manual
- UOM 8Plex 7Plex 6Plex 5Plex 4Plex 3Plex 2Plex1Plex
- FOB
US$ 437
US$ 454
US$ 479
US$ 512
US$ 546
US$ 596
US$ 672
Result
For more details, please contact local distributors! US$ 840 Add to Price Calculator
Specificity
This assay has high sensitivity and excellent specificity for detection of Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 88-96 | 92 |
EDTA plasma(n=5) | 79-89 | 84 |
heparin plasma(n=5) | 92-99 | 95 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 84-97% | 87-99% | 88-101% | 99-105% |
EDTA plasma(n=5) | 94-102% | 87-98% | 88-96% | 79-98% |
heparin plasma(n=5) | 94-102% | 83-95% | 80-93% | 85-103% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
96-well plate | 1 | Plate sealer for 96 wells | 4 |
Pre-Mixed Standard | 2 | Standard Diluent | 1×20mL |
Pre-Mixed Magnetic beads (22#:BCAR3) | 1 | Analysis buffer | 1×20mL |
Pre-Mixed Detection Reagent A | 1×120μL | Assay Diluent A | 1×12mL |
Detection Reagent B (PE-SA) | 1×120μL | Assay Diluent B | 1×12mL |
Sheath Fluid | 1×10mL | Wash Buffer (30 × concentrate) | 1×20mL |
Instruction manual | 1 |
Assay procedure summary
1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.
GIVEAWAYS
INCREMENT SERVICES
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
RPG768Hu01 | Recombinant Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAG768Hu01 | Polyclonal Antibody to Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) | WB; IHC; ICC; IP. |
MAG768Hu21 | Monoclonal Antibody to Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) | WB; IHC; ICC; IP. |
SEG768Hu | ELISA Kit for Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMG768Hu | Multiplex Assay Kit for Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |